diabetes-mellitus

Documents about diabetes-mellitus

• A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment.#146410ClinicalTrials.gov
• A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 Diabetes#146411ClinicalTrials.gov
• Effect of DapagliFLOzin on Quality of Life in Patients With Type 2 Diabetes in a Real Clinical PrActice#148720ClinicalTrials.gov
• Lantus Versus Humalog Mix as add-on Therapy in Type Diabetes Patients Failing Sulfonylurea and Metformin Combination Treatment#154877ClinicalTrials.gov
• Comparison of a Basal Plus One Insulin Regimen With a Biphasic Insulin Regimen in Type 2 Diabetes Patients#158169ClinicalTrials.gov
• A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin#160244ClinicalTrials.gov
• Study of Efficacy, Weight Control, and Safety in Newly-diagnosed Type 2 Diabetes With Different Antidiabetic Therapy#162391ClinicalTrials.gov
• Effect of Blood Flow Restricted Aerobic Exercise in Type 2 Diabetes Mellitus#162392ClinicalTrials.gov
• Open-label Investigation of the Safety and Effectiveness of DIABECELL® in Patients With Type 1 Diabetes Mellitus#175052ClinicalTrials.gov
• Efficacy and Safety of Vildagliptin as add-on Therapy to Metformin in Patients With Type 2 Diabetes#180360ClinicalTrials.gov
• A Study to Access the Efficacy in Type 2 Diabetes Mellitus on Stable Metformin#181724ClinicalTrials.gov
• Continuous Glucose Monitor in Children With Poorly Controlled Diabetes#184755ClinicalTrials.gov
• Efficacy and Safety of Vildagliptin Compared to Metformin in Elderly Drug Naive Patients With Type 2 Diabetes#195510ClinicalTrials.gov
• A Study of RO6811135 in Patients With Type 2 Diabetes Who Are Inadequately Controlled With Metformin#195524ClinicalTrials.gov
• Phase 1b/2a Study of GSBR-1290 in Adult Overweight or Obese Healthy Subjects and Subjects With Type 2 Diabetes Mellitus#162397ClinicalTrials.gov
• The Effect of Body Weight on Physical Activity Level, Functional Capacity, Balance, and Quality of Life in Individuals With Type 2 Diabetes Mellitus#201698ClinicalTrials.gov
• A Trial Comparing Insulin Degludec/Liraglutide and Insulin Degludec in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Therapy and Metformin With or Without One Other Oral Antidiabetic Drug (OAD)#127815ClinicalTrials.gov
• The Associations of Diabetes Mellitus and Obesity on Osteoporosis#13921bioRxiv / medRxiv
• Efficacy vs Placebo as Initial Combination Therapy With Pioglitazone#18801ClinicalTrials.gov
• Effect of Metformin on Exercise-induced Lipolysis#28560ClinicalTrials.gov
• Magnesium and Metabolic Syndrome#67727ClinicalTrials.gov
• Evaluation of Insulin Glargine Versus Sitagliptin in Insulin-naive Patients#67835ClinicalTrials.gov
• Alloxan blood levels and the risk of diabetes mellitus in children#108995PhilArchive
• Vildagliptin/Metformin in T2DM Patients Starting Basal Insulin#123391ClinicalTrials.gov
• Glycemic Evaluation of Novel Staple Foods#127755ClinicalTrials.gov
• Human Intestinal Peptides Evaluation and Research#136242ClinicalTrials.gov
• Developing Resiliency and Exercise Using AI-based Messaging#143740ClinicalTrials.gov
• Gestational and postpartum maternal consequences of gestational diabetes mellitus.#145937NCBI PubMed Central
• Remote And Decentralised Innovative Approaches to Clinical Trials (RADIAL)#146340ClinicalTrials.gov
• Use of Nutraceuticals in Clinical Practice#148604ClinicalTrials.gov
• Real-time Reminders To Decrease Late or Missed Meal Boluses#154825ClinicalTrials.gov
• Pediatrics Owning Performance Study#175063ClinicalTrials.gov
• Glucophage XR® Observational Study#175067ClinicalTrials.gov
• Transitioning Open Heart Surgery Patients From Insulin Infusions to Detemir#180280ClinicalTrials.gov
• Arginase Inhibition in Ischemia-reperfusion Injury#180309ClinicalTrials.gov
• Empagliflozin and Atrial Fibrillation Treatment#181684ClinicalTrials.gov
• Steroid-induced Diabetes Mellitus in Systemic Lupus Erythematosus (SLE) Patients#181707ClinicalTrials.gov
• Phase 4 Study in the Elderly Patients With T2DM#181733ClinicalTrials.gov
• IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045#7192OpenAlex
• Efficacy and Safety of Alogliptin vs. Acarbose in Chinese Type 2 Diabetes Mellitus (T2DM) Patients With High CV Risk or CHD Treated With Aspirin and Inadequately Controlled With Metformin Monotherapy or Drug Naive#67829ClinicalTrials.gov
• A Clinical Trial to Evaluate the Preference Regarding Convenience of Medication and Efficacy/Safety of SUGAMET®XR Tablet 5/1000mg#148714ClinicalTrials.gov
• Application of Artificial Intelligence in Early Detection of Eye Complications in Diabetics#158132ClinicalTrials.gov
• A Multiple Ascending Dose Study to Evaluate Safety and Tolerability of BFKB8488A in Participants With Type 2 Diabetes Mellitus and Participants With Non-Alcoholic Fatty Liver Disease#181667ClinicalTrials.gov
• Effect of Adding Metformin to Insulin Therapy on Pregnancy Outcomes in Women With Uncontrolled Type I Diabetes.#18531ClinicalTrials.gov
• Effects of Fatty Acid Delivery on Heart Metabolism and Function in Type 2 Diabetes (T2DM#18538ClinicalTrials.gov
• Effect of Diabetes Self-management Education and Support on Glycemic Control Among Patients With Type 2 Diabetic#18815ClinicalTrials.gov
• SIT LESS 2: Effect of Sitting Less on Glucose Regulation in People With Diabetes Mellitus Type 2#28522ClinicalTrials.gov
• An Open Study to Evaluate Whether Pack Size Affects Compliance of Metformin Treatment in Subjects With Type II Diabetes#123426ClinicalTrials.gov
• Photodynamic Therapy and Topical Antifungal for Onychomycosis in Patients With Diabetes.#123656ClinicalTrials.gov
• Safety and Efficacy of Bexagliflozin Compared to Sitagliptin as Add-on Therapy to Metformin in Type 2 Diabetes Subjects#127826ClinicalTrials.gov